These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 9174912)

  • 81. Roles of aromatic residues in high interfacial activity of Naja naja atra phospholipase A2.
    Sumandea M; Das S; Sumandea C; Cho W
    Biochemistry; 1999 Dec; 38(49):16290-7. PubMed ID: 10587453
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Phospholipase A2 affects the activity of fusicoccin receptors.
    Aducci P; Ballio A; Donini V; Fogliano V; Fullone MR; Marra M
    FEBS Lett; 1993 Apr; 320(2):173-6. PubMed ID: 8384573
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Structure and mechanism of human cytosolic phospholipase A(2).
    Dessen A
    Biochim Biophys Acta; 2000 Oct; 1488(1-2):40-7. PubMed ID: 11080675
    [TBL] [Abstract][Full Text] [Related]  

  • 84. A novel bifunctional mechanism of surface recognition by phospholipase A2.
    Heinrikson RL; Kézdy FJ
    Adv Exp Med Biol; 1990; 279():37-47. PubMed ID: 2096699
    [No Abstract]   [Full Text] [Related]  

  • 85. The X-ray structure of a snake venom Gln48 phospholipase A2 at 1.9A resolution reveals anion-binding sites.
    Georgieva DN; Perbandt M; Rypniewski W; Hristov K; Genov N; Betzel C
    Biochem Biophys Res Commun; 2004 Mar; 316(1):33-8. PubMed ID: 15003507
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Bacterial cytotoxins, amphotericin B and local anesthetics enhance transbilayer mobility of phospholipids in erythrocyte membranes. Consequences for phospholipid asymmetry.
    Schneider E; Haest CW; Plasa G; Deuticke B
    Biochim Biophys Acta; 1986 Mar; 855(3):325-36. PubMed ID: 3081027
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Fatty acid and phospholipid selectivity of different phospholipase A2 enzymes studied by using a mammalian membrane as substrate.
    Diez E; Chilton FH; Stroup G; Mayer RJ; Winkler JD; Fonteh AN
    Biochem J; 1994 Aug; 301 ( Pt 3)(Pt 3):721-6. PubMed ID: 8053897
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Amyloid-type fiber formation in control of enzyme action: interfacial activation of phospholipase A2.
    Code C; Domanov Y; Jutila A; Kinnunen PK
    Biophys J; 2008 Jul; 95(1):215-24. PubMed ID: 18339749
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Interaction of the macrolide antibiotic azithromycin with lipid bilayers: effect on membrane organization, fluidity, and permeability.
    Berquand A; Fa N; Dufrêne YF; Mingeot-Leclercq MP
    Pharm Res; 2005 Mar; 22(3):465-75. PubMed ID: 15835753
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Domain-induced activation of human phospholipase A2 type IIA: local versus global lipid composition.
    Leidy C; Linderoth L; Andresen TL; Mouritsen OG; Jørgensen K; Peters GH
    Biophys J; 2006 May; 90(9):3165-75. PubMed ID: 16461407
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Toward understanding interfacial activation of secretory phospholipase A2 (PLA2): membrane surface properties and membrane-induced structural changes in the enzyme contribute synergistically to PLA2 activation.
    Tatulian SA
    Biophys J; 2001 Feb; 80(2):789-800. PubMed ID: 11159446
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Interfacial enzymology of glycerolipid hydrolases: lessons from secreted phospholipases A2.
    Gelb MH; Jain MK; Hanel AM; Berg OG
    Annu Rev Biochem; 1995; 64():653-88. PubMed ID: 7574497
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Tryptophan-containing mutant of human (group IIa) secreted phospholipase A2 has a dramatically increased ability to hydrolyze phosphatidylcholine vesicles and cell membranes.
    Baker SF; Othman R; Wilton DC
    Biochemistry; 1998 Sep; 37(38):13203-11. PubMed ID: 9748327
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Membrane microstructural templates for enzyme domain formation.
    Maloney KM; Grandbois M; Salesse C; Grainger DW; Reichert A
    J Mol Recognit; 1996; 9(5-6):368-74. PubMed ID: 9174912
    [TBL] [Abstract][Full Text] [Related]  

  • 95.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 96.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 97.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 98.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 99.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.